|
(1) Packaging and labelling — the industry's role in patient safety
PDF (80K)
Clearer packaging and labelling of medicines helps minimise the risk of selection
errors. This article examines
some pharmacists’ views on how
the industry can help and looks at examples from companies who have
taken steps to improve the
packaging of their products
Hospital Pharmacist 2005;12;448-450 (December 2005)
|
(2) Purchasing safer medicines — a national risk assessment strategy
PDF (80K)
NHS purchasing groups can help reduce medicine-related errors by ensuring that
the medicines they purchase have been assessed for their error potential. This
article
describes factors involved in the
risk assessment process
Hospital Pharmacist 2006;13:17-19 (January 2006)
|
(3) Medication incident reports — improving the quality of reporting
PDF (50K)
Reports of medication incidents need to be accurate and complete for the NPSA
to identify error trends and disseminate safety information. This article describes
how review of incident reports by pharmacists improves the reliability of the
analysis
Hospital Pharmacist 2006;13:53-55 (February 2006)
|
(4) Medicines governance — increasing medication safety
PDF (50K)
A team of pharmacists in Northern Ireland has been established to increase
medication safety in secondary care. This article describes the implementation,
benefits and challenges of the medicines governance project
Hospital Pharmacist 2006;13:88-90 (March 2006)
|
(5) Failure modes and effects — a tool for evaluating packaging safety?
PDF (50K)
Failure modes and effects analysis is a tool that was developed outside of
health care but has been used in the US to evaluate the safety of medicines
packaging. This article describes how the approach, now being trialled on a
small scale in the UK, may fit in with existing risk reduction processes
Hospital Pharmacist 2006;13:173-175 (May 2006)
|
(6) Safe medication initiatives — sustaining good practice
PDF (60K)
This article, the last in the “safety of medicines in practice” series,
highlights examples of good practice in medication safety and how these initiatives
can be sustained and extended. Studies that have employed different methods
of measuring safe practice are also described
Hospital Pharmacist 2006;13:215-217 (June 2006)
|
